Language:
  
[Sign in] [Register]   

EIAab logo

Index > News Center > News list.
Enter your KeyWord (Ex. ELISA Kit, Cuticular Active Peptide Factor, etc)
search
Search content in infomation.

The risk of hip fracture associated with diabetes is attenuated when accounting for mortality risk in patients, according to research published in the Journal of Clinical Endocrinology & Metabolism.

Emma Hamilton, from the School of Medicine and Pharmacology, University of Western Australia in Crawley, and colleagues analyzed the risk for hip fracture among 1291 patients from the Fremantle Diabetes Study Phase I (FDS1) with type 2 diabetes and compared them with a matched group of 5159 patients without diabetes. Mean age was 64 ± 11.2 years, 48.7% were men, 1.5% of patients (n=19) had been hospitalized for hip fracture prior to the start of the study, and median diabetes duration was 4.0 years.

 

“[W]e found that the risk of incident hip fracture in our patients with type 2 diabetes was at the lower end of the range found in other studies employing conventional statistical methods, perhaps reflecting the multiracial, population-based nature of the FDS1 cohort and the validated categorization of diabetes type,” Watson and colleagues wrote. “However, the risk of hip fracture in our patients with diabetes was attenuated to nonsignificance after allowing for the competing risk of death.”

The researchers found the first hip fracture incident rate ratio (IRR) was 1.33 (95% CI, 1.05-1.68;P =.013) for patients with type 2 diabetes compared with the control group, with an age-, gender-, and comorbidity-adjusted cause-specific hazard ratio (HR) of 1.50 (95% CI, 1.19-1.89; P <.001) and subdistribution HR of 1.21 (95% CI, 0.96-1.52; P =.11) for patients with type 2 diabetes. 

Hamilton and colleagues also found that the use of insulin and renal impairment P ≤.015) were associated with cause-specific ......

Optical ‘Tractor Beam’ Traps Biological Cells

Posted by star on 2016-12-29 18:24:15
Hits:199

Physicists in Germany have developed a novel technique for trapping biological cells with a laser beam. Using this technique, the researchers obtained super-resolution images of chromosomal DNA within E. coli cells.

“One of the problems facing biologists who want to examine biological cells microscopically is that any preparatory treatment will change the cells,” the researchers said.

“Many bacteria prefer to be able to swim freely in solution. Blood cells are similar: they are continuously in rapid flow, and do not remain on surfaces. Indeed, if they adhere to a surface, this changes their structure and they die.”

“Our new method enables us to take cells that cannot be anchored on surfaces and then use an optical trap to study them at a very high resolution,” added Professor Thomas Huser, head of the Biomolecular Photonics Research Group in the Faculty of Physics at the University of Bielefeld and corresponding author of an article about the research that was published in the journal Nature Communications on Dec. 13, 2016.

“The cells are held in place by a kind of optical tractor beam. The principle underlying this laser beam is similar to the concept to be found in the television series Star Trek.”

Prof. Huser added: “what’s special is that the samples are not only immobilized without a substrate but can also be turned and rotated. The laser beam functions as an extended hand for making microscopically small adjustments.”

He and co-authors have further developed the procedure for use in super-resolution fluorescence microscopy.

“This is considered to be a key technology in biology and biomedicine because it delivers the first way to study biological processes in living cells at......

Scientists uncover new way to defeat therapy-resistant prostate cancer

Posted by star on 2016-12-29 18:22:09
Hits:184

A new study led by scientists from the Florida campus of The Scripps Research Institute (TSRI) sheds light on a signaling circuit in cells that drives therapy resistance in prostate cancer. The researchers found that targeting the components of this circuit suppresses advanced prostate cancer development.

 

The study, led by TSRI Associate Professor Jun-Li Luo, was published online ahead of print in the journal Molecular Cell.

A New Strategy to Fight Prostate Cancer

Prostate cancer—which, according to the American Cancer Society, affects one in six American men—is the second-leading cause of death after lung cancer in American men.

Currently, the most effective treatment of advanced prostate canceris to deprive the cancer of what feeds it—androgen hormones such as testosterone. Unfortunately, almost all patients eventually develop resistance to this therapy, leaving doctors with no options to counteract the inevitable.

The new study shows that a "constitutively active" signaling circuit can trigger cells to grow into tumors and drive therapy resistance in advanced prostate cancer. A cell signal pathway with constitutive activity requires no binding partner (ligand) to activate; instead, the signaling circuit continually activates itself.

This signaling circuit, which is composed of the protein complex IκBα/NF-κB (p65) and several other molecules, controls the expression of stem cell transcription factors (proteins that guide the conversion of genetic information from DNA to RNA) that fuel the aggressive growth of these resistant cancer cells.

"The fact that the constitutive activation of NF-kB in the circuit is independent of traditional activation opens the door for potential treatment options," said Luo.

Targeti......

Hot Pepper Compound Inhibits Growth of Breast Cancer Cells

Posted by star on 2016-12-29 18:07:27
Hits:198

Capsaicin, a compound found in peppers of the genus Capsicum, inhibits the growth of breast cancer cells, according to a team of researchers in Germany.

The team’s experiments were carried out with the SUM149PT cell culture, a model system for a particularly aggressive type of breast cancer, i.e. the triple-negative type.

In the cultivated cells, the researchers detected a number of typical olfactory receptors.

“One receptor occurred very frequently; it is usually found in the fifth cranial nerve. It belongs to the so-called transient receptor potential channels and is named TRPV1 (transient receptor potential vanilloid receptor),” they explained.

“That receptor is activated by the spicy molecule capsaicin as well as by helional, a scent of fresh sea breeze.”

The authors confirmed the existence of TRPV1 in tumor cells in nine different samples from patients suffering from breast cancer.

They activated the TRPV1 receptor in the cell culture with capsaicin or helional, by adding the substances to the culture for a period of several hours or days. As a result, the cancer cells divided more slowly.

Moreover, the treatment caused tumor cells to die in larger numbers.

The surviving cells were no longer able to move as quickly as heretofore; this implies that their ability to form metastases in the body was impeded.

“If we could switch on the TRPV1 receptor with specific drugs, this might constitute a new treatment approach for this type of cancer,” said Prof. Hanns Hatt, from the Department of Cell Physiology at the Ruhr-University Bochum.

“An intake......


Artemisinin occurs naturally in the leaves of the sweet wormwood, a sweetly aromatic herb with small, yellow flower heads and the source of the Traditional Chinese Medicine ‘Qing Hao.’

The compound is a potent anti-malarial agent, and can kill highly drug-resistant strains.

In the new study, artemisinin stopped the ability of Mycobacterium tuberculosis(Mtb), the causative agent of tuberculosis, to become dormant. This stage of the disease often makes the use of antibiotics ineffective.

“When Mtb are dormant, they become highly tolerant to antibiotics. Blocking dormancy makes the bacteria more sensitive to these drugs and could shorten treatment times,” Dr. Abramovitch said.

Mtb needs oxygen to thrive in the body. The immune system starves this bacterium of oxygen to control the infection.

Dr. Abramovitch and co-authors found that artemisinin attacks a molecule called heme, which is found in the Mtb oxygen sensor.

By disrupting this sensor and essentially turning it off, artemisinin stopped the disease’s ability to sense how much oxygen it was getting.

“When the Mtb is starved of oxygen, it goes into a dormant state, which protects it from the stress of low-oxygen environments. If Mtb can’t sense low oxygen, then it can’t become dormant and will die,” Dr. Abramovitch said.

The researchers indicated that dormant Mtb can remain inactive for decades in the body. But if the immune system weakens at some point, it can wake back up and spread. Whether it wakes up or stays ‘asleep’ though, Mtb can take up to six months to treat and is one of the main reasons the disease is so difficult to control.

After screening 540,000 different compounds, the authors also found five other possible chemical inh......

Page 2 of 68
Hot Genes
ALCAM ACE KSR2 ASPRO C19orf80 Gdf5 Trap1a Atf2
Top Searches
Asprosin Ubiquitin ELISA Ubiquitin-protein ligase TRAP1A metalloproteinase Tumor necrosis vitamin d
Why choose EIAAB
Our products have been quoted by many publications in famous journals such as Cell; Cell Metabolism; Hepatology; Biomaterials.more
Further Information
About us Protein center Bank account Distributors Terms & Conditions Career eiaab.cn

Copyright & copy www.eiaab.com2006-2016 All Rights Reserved    EIAab         Email:eiaab@eiaab.com

Twitter